Unified Multi-Physics Validation and Fabrication Blueprint for Sub-Diffraction Oncological Biosensing

Traditional label-free biosensing and near-field scanning optical microscopy (NSOM) are fundamentally constrained by the Abbe diffraction limit and the catastrophic ohmic thermal losses inherent to plasmonic metallic nanostructures. This release presents the v3.0 unified validation of the MALT-NSOM (Metal-Assisted Lossless-Dielectric Nanophotonic Sub-diffraction Optical Microscopy) platform. The architecture utilizes a high-index dielectric Hafnium Oxide (HfO2) dimer cavity to achieve extreme sub-diffraction light confinement. Through rigorous multi-physics modeling using 3D Finite-Difference Time-Domain (MEEP), Finite Element Analysis (FEniCS), and Acoustic Tensor (k-Wave) solvers, this study establishes the physical viability of the platform across three core domains: OPTICS (MEEP): We verify that a locked physical gap of 16.57 nm, under 180 nm Deep-UV excitation, compresses light into a spatial node with a peak intensity enhancement factor of 20.69. This creates a lossless optical "tripwire" for single-molecule scanning. THERMODYNAMICS & INDUCTION (FEniCS): We demonstrate that the all-dielectric architecture eliminates ohmic heating, restricting the operational thermal delta to +0.1478 Celsius. Furthermore, we validate the integration of bioresorbable magnesium implants as active antennas for 15 Hz PEMF magnetic induction, achieving localized voltage gradients suitable for accelerated osteogenesis and marrow stimulation. ACOUSTIC INTERVENTION (k-Wave): We present a 3D helical-conical transducer array simulation, multiplexing 2 MHz and 100 kHz frequencies. This geometry generates rotational mechanical shear and localized standing-wave trapping pockets capable of transient Blood-Brain Barrier (BBB) modulation and non-invasive disruption of heterogeneous Glioblastoma (GBM) tumor cores, while maintaining sub-cavitation pressure thresholds. Biosensing perturbation analysis confirms a measurable +27.20 percent signal spike upon single-molecule (10 nm) biomarker entry into the cavity, proving the platform's diagnostic efficacy. With a trapping force of 0.4303 pN—over 40 times stronger than Brownian motion—the architecture is mathematically optimized for automated single-molecule capture. This dossier constitutes the final technical requirement for cleanroom fabrication, establishing a scalable, thermally stable, and non-invasive pipeline for both label-free clinical diagnostics and targeted oncological therapy.